| Identification | Back Directory | [Name]
Benzenemethanol, 4-bromo-α-butyl-2-(2H-tetrazol-5-yl)- | [CAS]
2563616-64-6 | [Synonyms]
Benzenemethanol, 4-bromo-α-butyl-2-(2H-tetrazol-5-yl)- | [Molecular Formula]
C12H15BrN4O | [MOL File]
2563616-64-6.mol | [Molecular Weight]
311.18 |
| Chemical Properties | Back Directory | [Boiling point ]
498.7±55.0 °C(predicted) | [density ]
1.485±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [pka]
4.05±0.10(predicted) |
| Hazard Information | Back Directory | [Uses]
Anti-apoptotic agent 1 (Compound B4) exhibits neuroprotective activity and good pharmacokinetic properties. Anti-apoptotic agent 1 inhibits apoptosis, prevents stroke recurrence in photothrombotic rat model[1]. | [References]
[1] Lu Y, et al., Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke. Eur J Med Chem. 2024 Jun 1;275:116542. DOI:10.1016/j.ejmech.2024.116542 |
|
|